Skip to main content
. 2013 Jul 17;2013(7):CD004185. doi: 10.1002/14651858.CD004185.pub3

Li 2006c.

Methods Four‐week, randomised study
Participants Patients with depression according to CCMD‐III criteria
Interventions Sixty patients randomised to fluoxetine or reboxetine
Fluoxetine dose range: 4‐8 mg
Reboxetine dose range: 20‐40 mg
Outcomes Hamilton Depression Rating Scale (HDRS) and Clinical Global Impression (CGI)
Notes Waiting for translation from Chinese to English (only abstract available in English)